SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-121366
Filing Date
2021-04-19
Accepted
2021-04-19 16:54:52
Documents
3
Period of Report
2021-06-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A d52646ddef14a.htm DEF 14A 305324
2 GRAPHIC g52646pc_1.jpg GRAPHIC 134565
3 GRAPHIC g52646pc_2.jpg GRAPHIC 102737
  Complete submission text file 0001193125-21-121366.txt   633213
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Filer) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39041 | Film No.: 21835200
SIC: 2834 Pharmaceutical Preparations